Transactions.
More than 100 transactions across M&A, capital raising, and strategic advisory, spanning a decade of advising great companies at every stage of their lives.
104
Transactions
10+
Years
3
Continents
All Transactions.
Loading transactions
March 2026
On its sale to
Sell Side M&A
November 2025
on its exclusive license agreement with
Strategic Advisory
November 2025
On its $40mm Series B-2 round with participation from
and other existing investors
Capital RaisingHealthcare
September 2025
On its acquisition of
from
Buy Side M&AHealthcare
July 2025
On the sale of its Luxfer Graphic Arts business to
a portfolio company of
CarveoutSell Side M&A
April 2025
Strategic & financial advisor
Strategic Advisory
December 2024
On its acquisition of
Buy Side M&A
December 2024
Co-manager on its $625mm Convertible Senior Notes Offering
Capital Raising
September 2024
On its sale to
Cross-BorderSell Side M&A
September 2024
On its sale to
a portfolio company of
Sell Side M&A
August 2024
Co-manager on its $400mm Convertible Senior Notes Offering
Capital Raising
July 2024
On its sale to
Sell Side M&A
MARQUEE MANDATE · HEALTHCARE
XMS advised Exact Sciences from its earliest capital raises to its ~$23B sale to Abbott.
Let’s talk about where your company is headed.
Whether you are raising your first institutional round or weighing a defining sale, the conversation starts with senior bankers who will stay with you for the life of the company.